ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 213 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,492,000 | -22.2% | 444,679 | -8.4% | 0.11% | -15.7% |
| Q4 2017 | $7,061,000 | +4.4% | 485,306 | +2.1% | 0.13% | +4.1% |
| Q3 2017 | $6,763,000 | +270.8% | 475,273 | +243.2% | 0.12% | +248.6% |
| Q3 2016 | $1,824,000 | -51.0% | 138,475 | -52.8% | 0.04% | -53.3% |
| Q2 2016 | $3,724,000 | -2.3% | 293,203 | +1.6% | 0.08% | -3.8% |
| Q1 2016 | $3,813,000 | +66.4% | 288,652 | +93.7% | 0.08% | +69.6% |
| Q4 2015 | $2,292,000 | +23.7% | 149,049 | -0.3% | 0.05% | +21.1% |
| Q3 2015 | $1,853,000 | -20.2% | 149,443 | -0.5% | 0.04% | -11.6% |
| Q4 2013 | $2,321,000 | -10.5% | 150,143 | -13.9% | 0.04% | -14.0% |
| Q3 2013 | $2,594,000 | -72.0% | 174,424 | -75.6% | 0.05% | -73.4% |
| Q2 2013 | $9,252,000 | – | 714,998 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
| Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
| GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
| DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
| S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
| Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
| Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |